- Citations, last 5 years
- 7 067
- Works, last 5 years
- 888
- h-index
- 177
- Scientists listed
- 91
- Grants since 2016
- 849
Grants received
2022–2027 · research · R01
Rational development of a vaccine against tick-borne rickettsioses
Rong Megan Fang · Texas A&M University at Galveston · funded by National Institutes of Health
2022–2027 · research · R01
Immunotherapy Targeting Tau Aggregate Polymorphs
Rakez Kayed · Texas A&M University at Galveston · funded by National Institutes of Health
2022–2027 · grant · D43
Training and Research on Arboviruses and Zoonoses In Nigeria and Sierra Leone (TRAIN)
Nathan Yakubu Shehu · Texas A&M University at Galveston · funded by National Institutes of Health
2022–2027 · cooperative agreement · UH3
3-D biofabricated feto-maternal interface tissue model to determine drug efficacy during pregnancy to reduce the risk of preterm birth
Arum Han · Texas A&M University at Galveston · funded by National Institutes of Health
2022–2027 · research · R01
The Role of Ubiquitination in Tau Oligomers Pathogenesis
Rakez Kayed · Texas A&M University at Galveston · funded by National Institutes of Health
2022–2027 · cooperative agreement · U2R
2/2 - Mongolian Center for Environmental & Occupational Health - U.S.
Davaalkham - Dambadarjaa · Texas A&M University at Galveston · funded by National Institutes of Health
2022–2027 · cooperative agreement · U24
An Educational Program to Enhance Data Quality and Integrity for Regulated Studies Supporting the Advancement of Medical Countermeasures for High Consequence Pathogens
Trevor Brasel · Texas A&M University at Galveston · funded by U.S. Food and Drug Administration
2022–2027 · research · RM1
Understanding the Mechanistic, Neurophysiological, and Antinociceptive Effects of Transcutaneous Auricular Neurostimulation for Treatment of Chronic Pain
Jeffrey J Borckardt · Texas A&M University at Galveston · funded by National Institutes of Health
2022–2027 · cooperative agreement · U24
An Educational Program to Enhance Data Quality and Integrity for Regulated Studies Supporting the Advancement of Medical Countermeasures for High Consequence Pathogens
Trevor Brasel · Texas A&M University at Galveston · funded by U.S. Food and Drug Administration
2022–2027 · career development · K01
Sex Differences in Pain and Treatment and their Association with Alzheimer’s Disease and Related Dementias
Sadaf Arefi Milani · Texas A&M University at Galveston · funded by National Institutes of Health
2022–2027 · research · R01
Nano-Pulsed Optoacoustic Neuromodulation for Reducing Traumatic Brain Injury-Driven Neuropathology and Improving Cognitive Outcome
Rinat O. Esenaliev · Texas A&M University at Galveston · funded by National Institutes of Health
2022–2025 · cooperative agreement · U19
Discovery of Novel Broad-Spectrum Coronavirus Mpro Inhibitors
Julien Papillon · Texas A&M University at Galveston · funded by National Institutes of Health
2022–2025 · cooperative agreement · U19
High Throughput Biology Core
Ujjini Havaldar Manjunatha · Texas A&M University at Galveston · funded by National Institutes of Health
2022–2025 · cooperative agreement · U19
Discovery of novel broad-spectrum coronavirus inhibitors
Vineet D Menachery · Texas A&M University at Galveston · funded by National Institutes of Health
2022–2025 · cooperative agreement · U19
Administrative Core
Vineet D Menachery · Texas A&M University at Galveston · funded by National Institutes of Health
2021–2026 · research · R01
AIM(2)ing at the inflammasome: Impact of MAVS signaling in cocaine-and HIV-1 induced neuroinflammation
Irma Cisneros · Texas A&M University at Galveston · funded by National Institutes of Health
2021–2023 · research · R21
Developing effective nanovaccines against pathogenic Escherichia coli
Alfredo G Torres · Texas A&M University at Galveston · funded by National Institutes of Health
2021–2024 · research · R21
Therapeutic efficacy of favipiravir against henipavirus infections
Alexander Niclas Freiberg · Texas A&M University at Galveston · funded by National Institutes of Health
2021–2026 · research · R01
Preclinical development of a vaccine for Nipah virus
Thomas William Geisbert · Texas A&M University at Galveston · funded by National Institutes of Health
2021–2026 · research · R01
Modulation of BRD4 to epigenetically suppress HIV
Haitao Hu · Texas A&M University at Galveston · funded by National Institutes of Health
2021–2024 · career development · K01
Examining the Physical, Mental, and Social Health Outcomes Among Commercial Fishers to Inform Policy and Practice
Shannon Paige Guillot-Wright · Texas A&M University at Galveston · funded by National Institute for Occupational Safety and Health
2021–2026 · grant · DP2
Revealing the Biophysics of the Germinal Center Microenvironment
Robert Koehler Abbott · Texas A&M University at Galveston · funded by National Institutes of Health
2021–2026 · training · T32
Physician-Scientist Training in Emerging Infectious Diseases
Peter C. Melby · Texas A&M University at Galveston · funded by National Institutes of Health
2021–2026 · research · R01
Preclinical development of a vaccine for Nipah virus
Thomas William Geisbert · Texas A&M University at Galveston · funded by National Institutes of Health
2021–2026 · research · R01
Tau oligomer conformers and synaptic vulnerability/resilience in AD and related disorders
Agenor Limon · Texas A&M University at Galveston · funded by National Institutes of Health
2021–2026 · research · R01
Pathogenesis of HIV-associated sensory neuropathy
Subo Yuan · Texas A&M University at Galveston · funded by National Institutes of Health
2021–2026 · training · T32
Physician-Scientist Training in Emerging Infectious Diseases
Peter C. Melby · Texas A&M University at Galveston · funded by National Institutes of Health
2021–2023 · fellowship · F31
Roles of Pteropine Bat and Human TRIMs in Regulating Henipavirus Infection
Sarah Van Tol · Texas A&M University at Galveston · funded by National Institutes of Health
2021–2022 · fellowship · F31
Roles of Pteropine Bat and Human TRIMs in Regulating Henipavirus Infection
Sarah Van Tol · Texas A&M University at Galveston · funded by National Institutes of Health
2021–2024 · award
Assessing the Impact of Seismic Airguns on Commercially and Recreationally-important Fish
Texas A&M University at Galveston · funded by Bureau of Ocean Energy Management
2021–2026 · grant · DP2
Revealing the Biophysics of the Germinal Center Microenvironment
Robert Koehler Abbott · Texas A&M University at Galveston · funded by National Institutes of Health
2021–2025 · research · R21
Mincle and STING Activation in Proinflammatory Responses to Orientia Infection
Lynn Soong · Texas A&M University at Galveston · funded by National Institutes of Health
2021–2026 · research · R01
Mechanisms of Synaptic Protection in Cognitive Resilence to Alzheimer's Disease Neuropathology
Agenor Limon · Texas A&M University at Galveston · funded by National Institutes of Health
2021–2026 · research · R01
Mechanisms of Synaptic Protection in Cognitive Resilence to Alzheimer's Disease Neuropathology
Agenor Limon · Texas A&M University at Galveston · funded by National Institutes of Health
2021–2027 · research · R01
Modulation of BRD4 to epigenetically suppress HIV
Haitao Hu · Texas A&M University at Galveston · funded by National Institutes of Health
2021–2026 · research · R01
Evaluating telementoring to initiate a multidimensional diabetes program for Latino(a)s in community clinics: A Randomized Clinical Trial
Elizabeth M Vaughan · Texas A&M University at Galveston · funded by National Institutes of Health
2021–2026 · cooperative agreement · U24
Interdisciplinary Research Network on Biologically Active Tau Aggregate Polymorphs from Alzheimer's Disease and Related Dementias
David Eisenberg · Texas A&M University at Galveston · funded by National Institutes of Health
2021–2026 · grant · DP2
Revealing the Biophysics of the Germinal Center Microenvironment
Robert Koehler Abbott · Texas A&M University at Galveston · funded by National Institutes of Health
2021–2026 · program · P01
Molecular Mechanisms of the Dysregulated Immune Response to Ebola Virus
Alexander Bukreyev · Texas A&M University at Galveston · funded by National Institutes of Health
2021–2027 · research · R01
Preclinical development of a vaccine for Nipah virus
Thomas William Geisbert · Texas A&M University at Galveston · funded by National Institutes of Health